Malignant Hyperthermia: A Review of Current Concepts

Abstract

Get full access to this article

View all access options for this article.

References

Britt

. Malignant hyperthermia. Can Anaesth Soc J 1985;32(6):666–667.

Britt

, Kalow

Malignant hyperthermia: A statistical review. Can Anaesth Soc J 1970;17:293–315.

Tomarken

, Britt

. Malignant hyperthermia. Ann Emerg Med 1987;16(11):1253–1265.

Wilhoit

, Brown

Jr , Bauman

. Possible malignant hyperthermia in a 7 week old infant. Anesth Analg 1989;68(5):688–691.

Kripke

, Blanck

TJJ

, Sizemore

, Comunale

, Gruener

Association of post-anaesthetic hyperthermia with abnormal muscle characteristics: A case report. Can Anaesth Soc J 1983;30(3):290–294.

Larach

, Rosenberg

, Larach DR , Broennle

. Prediction of malignant hyperthermia susceptibility by clinical signs. Anesthesiology 1987;66(4):547–550.

Jensen

, Bach

, Werner

, Neilsen

, Jensen

. A fatal case of malignant hyperthermia following isoflurane anaesthesia. Acta Anaesthesiol Scand 1986;30:293–294.

Johannesson

, Veel

, Rogstadius

Malignant hyperthermia during isoflurane anaesthesia: A case report. Acta Anaesthesiol Scand 1987;31(3):231–232.

Moore

. Ester or amide local anesthetics in malignant hyperthermia-Who knows? Anesthesiology 1986;64(2):294–296.

10.

Paasuke

, Brownell

AKW

. Amide local anesthetics and malignant hyperthermia. Can Anaesth Soc J 1986;33(2):126–129.

11.

Brownell

AKW

, Paasuke

. Use of local anesthetics in malignant hyperthermia. Can Med Assoc J 1986;134:993–994.

12.

Merigian

, Roberts JR . Cocaine intoxication: Hyperpyrexia, rhabdomyolysis and acute renal failure. J Toxicol Clin Toxicol 1987;25(1-2):135–148.

13.

Loghmanee

, Tobak

Fatal malignant hyperthermia with recreational cocaine and ethanol abuse. Am J Forensic Med Pathol 1986;7(3):246–248.

14.

Gronert

. Malignant hyperthermia. Anesthesiology 1980;53(5):395–423.

15.

Steward

. Malignant hyperthermia-The acute crisis. In: Britt

, ed. Malignant hyperthermia. Int Anesthesiol Clin 1979;17:1–9.

16.

Heffron

JJA

. Malignant hyperthermia: Biochemical aspects of the acute episode. Br J Anaesth 1988;60(3):274–278.

17.

Baudendistel

, Goudsouzian

, Cote

, Strafford

End-tidal CO₂ monitoring: Its use in the diagnosis and management of malignant hyperthermia. Anaesthesia 1984;39:1000–1003.

18.

Triner

, Sherman

Potential value of expiratory carbon dioxide measurement in patients considered to be susceptible to malignant hyperthermia. Anesthesiology 1981;55:482.

19.

Atkinson

, Rushman

, Lee

. A synopsis of anaesthesia. England: IOP Publishing Limited, 1987.

20.

Bacon

. Pulse oximetry in malignant hyperthermia. Anaesth Intensive Care 1989;17(2):208–210.

21.

Wlody

. Malignant hyperthermia-Potential crisis in patient care. AORN J 1989;50(2):286–290.

22.

Leiding

, Graham

. Malignant hyperthermia. Arch Otolaryngol 1981;107:758–760.

23.

Bloom

, Iwamoto

, Reynolds

, Ehrlich

. Management of malignant hyperthermia. J Urol 1981;125(4):594–597.

24.

Ryan

, Donlon

, Malt

, . Cardiopulmonary bypass in the treatment of malignant hyperthermia. N Engl J Med 1974;290(20):1121–1122.

25.

Kellam

AMP

. The neuroleptic malignant syndrome, so-called-A survey of the world literature. Br J Psychiatry 1987;150:752–759.

26.

Abbott

, Loizou

. Neuroleptic malignant syndrome. Br J Psychiatry 1986;148:47–51.

27.

Adnet

, Krivosic-Horber

, Adamantidis

, . The association between neuroleptic malignant syndrome and malignant hyperthermia. Acta Anaesthesiol Scand 1989;33(8):676–680.

28.

Gronert

, Hilde

, Theye

. Dantrolene in porcine malignant hyperthermia. Anesthesiology 1976;44(6):488–495.

29.

Kerr

, Jones

, Nelson

, Gatz

. Treatment of malignant hyperthermia in swine. Anesth Analg 1973;52(5):734–739.

30.

Ryan

. Treatment of acute hyperthermia crises. In: Britt

, ed. Malignant hyperthermia. Int Anesthesiol Clin 1979;17:153–168.

31.

Schmalbruch

A freeze-fracture study of the plasma membrane of muscle fibers of a patient with chronic creatine kinase elevation suspected for malignant hyperthermia. J Neuropathol Exp Neurol 1979;38:407–418.

32.

Mathieu

, Bogosian

, Ryan

, Crone

, Crocker

Recrudescence after survival of an initial episode of malignant hyperthermia. Anesthesiology 1979;51(5):454–455.

33.

Harrison

. Control of malignant hyperpyrexia syndrome in MHS swine by dantrolene sodium. Br J Anaesth 1975;47:62–65.

34.

Pandit

, Kothary

, Cohen

. Orally administered dantrolene for prophylaxis of malignant hyperthermia. Anesthesiology 1979;50:156–158.

35.

Kolb

, Horne

, Martz

. Dantrolene in human malignant hyperthermia. Anesthesiology 1982;56:254–262.

36.

Britt

. Dantrolene. Can Anaesth Soc J 1984;31(1):61–75.

37.

Cuncliffe

, Lerman

, Britt

. Is prophylactic dantrolene indicated for malignant hyperthermia susceptible patients undergoing elective surgery? Can Anaesth Soc J 1986;33(Part 2):S113.

38.

Fitzgibbons

. Malignant hyperthermia following pre-operative oral administration of dantrolene. Anesthesiology 1981;54:73–75.

39.

Ruhland

, Hinkle

. Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia. Anesthesiology 1984;60:159–160.

40.

Wingard

. Controversies regarding the prophylactic use of dantrolene for malignant hyperthermia (letter). Anesthesiology 1983;58:489–490.

41.

Flewellen

, Nelson

. Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia (letter). Anesthesiology 1984;61:477.

42.

Harrison

. Dantrolene-Dynamics and kinetics. Br J Anaesth 1988;60(3):279–286.

43.

Watson

, Reierson

, Norfleet

. Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia. Anesthesiology 1986;65:312–314.

44.

Driessen

, Wuis

, Gielen

MJM

. Prolonged vecuronium neuromuscular blockade in a patient receiving orally administered dantrolene. Anesthesiology 1985;62(4):523–524.

45.

Aldrete

. Advances in the diagnosis and treatment of malignant hyperthermia. Acta Anaesthesiol Scand 1981;25:477–483.

46.

Denborough

, Ebeling

, King

, Zapf

Myopathy and malignant hyperpyrexia. Lancet 1970;1:1138–1140.

47.

Brownell

AKW

, Paasuke

, Elash

, . Malignant hyperthermia in Duchenne muscular dystrophy. Anesthesiology 1983;58:180–182.

48.

Denborough

, Dennett

, Anderson

RMD

. Central core disease and malignant hyperpyrexia. Br Med J 1973;1:272–274.

49.

Ryan

, Al-Ghandi

, Gayle

, Finer

. Osteogenesis imperfecta and hyperthermia. Anesth Analg 1989;68(6):811–814.

50.

Britt

. Preanesthetic diagnosis of malignant hyperthermia. In: Britt

, ed. Malignant hyperthermia. Int Anesthesiol Clin 1979;17:63–96.

51.

Ording

Diagnosis of susceptibility to malignant hyperthermia in man. Br J Anaesth 1988;60(3):287–302.

52.

Melton

, Martucci

, Kien

, Gronert

. Malignant hyperthermia in humans-Standardization of contracture testing protocol. Anesth Analg 1989;69:437–443.

53.

Larach

. Standardization of the caffeine halothane muscle contracture test. Anesth Analg 1989;69(4):511–515.

54.

Kalow

, Britt

, Chen

. Epidemiology and inheritance of malignant hyperthermia. In: Britt

, ed. Malignant hyperthermia. Int Anesthesiol Clin 1979;17:119–139.

55.

Donlon

, Newfield

, Sreter

, Ryan

. Implications of masseter spasm after succinylcholine. Anesthesiology 1987;49(4):298–301.

56.

Schwartz

, Koka

, Rockoff

. Masseter spasm after halothane and succinylcholine: Incidence and implications (abstract). Anesthesiology 1983;59(3):A438.

57.

Flewellen

, Nelson

. Halothane-succinylcholine induced masseter spasm: Indicative of malignant hyperthermia susceptibility? Anesth Analg 1984;63:693–697.

58.

Rosenberg

, Fletcher

. Masseter muscle rigidity and malignant hyperthermia susceptibility. Anesth Analg 1986;65:161–164.

59.

Ohnishi

, Katagi

, Ohnishi

, Brownell

AKW

. Detection of malignant hyperthermia susceptibility using a spin label technique on red blood cells. Br J Anaesth 1988;61(5):565–568.

60.

Olein

, Arzov

, Rosenberg

, Tuchler

, Chance

Non-invasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy. Anesthesiology 1988;68(4):507–513.

61.

Klip

, Ramlal

, Walker

, Britt

, Elliot

. Selective increase in cytoplasmic calcium by anesthetic in lymphocytes from malignant hyperthermia-susceptible pigs. Anesth Analg 1987;66(5):381–385.

62.

Amaranath

, Lavin

, Trusso

, Boutros

. Evaluation of creatine phosphokinase screening as a predictor of malignant hyperthermia. Br J Anaesth 1983;55(6):531–533.

63.

Britt

, Endrenyi

, Kalow

, Peters

. The adenosine triphosphate (ATP) depletion test: Comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility. Can Anaesth Soc J 1976;23:624–635.

64.

Allen

, Ryan

, Jones

, . Sarcoplasmic reticulum calcium uptake in cryostat sections of skeletal muscle from malignant hyperthermia patients and controls. Muscle & Nerve 1986;9:474–475.

65.

Harrison

, Verburg

Erythrocyte osmotic susceptibility in hyperthermia-susceptible swine. Br J Anaesth 1973;45:131–133.

66.

Tolpin

, Fletcher

, Rosenberg

, Michaux

Effects of anesthetic agents in erythrocyte fragility: Comparison of normal and malignant hyperthermia susceptible patients. Can J Anaesth 1987;34(4):366–372.

67.

Reynolds

, Reynolds

, Henschel

. Physical exercise in malignant hyperthermia screening. Lancet 1981;2:303.

68.

MacLennan

, Duff

, Zorzato

, . Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 1990;343:559–562.

69.

McCarthy

, Healy

JMS

, Heffron

JJA

, . Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 1990;343:562–564.

70.

McPherson

, Taylor

Jr . The King syndrome: Malignant hyperthermia, myopathy and multiple anomalies. Am J Med Genet 1981;8:154–165.

71.

Kousseff

, Nichols

A new autosomal recessive syndrome with Noonan-like phenotype, myopathy with congenital contractures and malignant hyperthermia. Birth Defects 1985;21(2):111–117.

72.

Nelson

. SR function in malignant hyperthermia. Cell Calcium 1988;9(5-6):257–265.

73.

Britt

, Kalow

, Gordon

, Humphrey

, Newcastle

. Malignant hyperthermia: An investigation of five patients. Can Anaesth Soc J 1973;20(4):431–467.

74.

Allen

, Ryan

, Sreter

, Mabuchi

Rigid vs non-rigid malignant hyperthermia. Studies of Ca uptake and actinomyosin ATPase (abstract). Anesthesiology 1980;53(3):S251.

75.

O'Brien

. Porcine malignant hyperthermia susceptibility: Hypersensitive calcium release mechanism of skeletal muscle sarcoplasmic reticulum. Can J Vet Res 1986;50(3):318–328.

76.

Lopez JR , Alamo

, Caputo

, Wikinski

, Ledezma

Intracellular ionized calcium concentration in muscles from humans with malignant hyperthermia. Muscle & Nerve 1985;8:355–358.

77.

Condrescu

, Lopez JR , Medina

, Alamo

Deficient function of the sarcoplasmic reticulum in patients susceptible to malignant hyperthermia. Muscle & Nerve 1987;10(3):238–241.

78.

Ohnishi

, Waring

, Fang

SRG

, . Abnormal membrane properties of the sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia: Modes of action of halothane, caffeine, dantrolene and two other drugs. Arch Biochem Biophys 1986;247(2):294–301.

79.

Moulds

RFW

, Denborough

. Biochemical basis of malignant hyperthermia. Br Med J 1974;2:241–244.

80.

Klip

, Britt

, Elliot

, Walker

, Ramlal

, Pege

Changes in cytoplasmic-free calcium caused by halothane: Role of the plasma membrane cell intracellular Ca stores. Biochem Cell Biol 1986;64(11):1181–1189.

81.

Mickelson JR , Ross

, Hyslop

, Gallant

, Louis

. Skeletal muscle sarcolemma in malignant hyperthermia: Evidence for a defect in calcium regulation. Biochim Biophys Acta 1987;897(3):364–376.

82.

Rock

, Kozak-Reiss

Effect of halothane on the Ca-transport system of surface membranes isolated from normal and malignant hyperthermia pig skeletal muscle. Arch Biochem Biophys 1987;256(2):703–707.

83.

Cheah

, Cheah

. Skeletal muscle mitochondrial phospholipase A2 and the interaction of mitochondria and sarcoplasmic reticulum in porcine malignant hyperthermia. Biochim Biophys Acta 1981;638(1):40–49.

84.

Fletcher

, Rosenberg

, Hilf

Possible phospholipase A2 involvement in human malignant hyperthermia (abstract). Anesthesiology 1984;61(3A):A252.

85.

Fletcher

, Rosenberg

In vitro muscle contractures induced by halothane and suxamethonium II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients. Br J Anaesth 1986;58(2):1433–1439.

86.

Messineo

, Rathier

, Favreau

, Watras

, Takenaka

Mechanisms of fatty acid effects on sarcoplasmic reticulum. J Biol Chem 1984;259(2):1336–1343.

87.

Stadhouders

, Viering

WAL

, Verburg

, Ruitenbeek

, Sengers

RCA

. In vivo induced malignant hyperthermia in pigs III: Localization of calcium in skeletal muscle mitochondria by means of electromicroscopy and micro-probe analysis. Acta Anaesthesiol Scand 1984;28:14–26.

88.

Verburg

, Oerlemans

FTJJ

, Van Bennekom

, Gielen

MJM

, DeBroyn

CHMM

, Crul

. In vivo induced malignant hyperthermia in pigs I: Physiological and biochemical changes and the influence of dantrolene sodium. Acta Anaesthesiol Scand 1984;28:1–8.

89.

Ruitenbeek

, Verburg

, Janssen

AJM

, Stadhouders

, Sengers

RCA

. In vivo induced malignant hyperthermia in pigs II: Metabolism of skeletal muscle mitochondria. Acta Anaesthesiol Scand 1984;28:9–13.

90.

Mitchell

, Heffron

JJA

, Van Rensburg

AJJ

. A halothane-induced biochemical defect in muscle of normal and malignant hyperthermia-susceptible landrace pigs. Anesth Analg 1980;59:250–256.

91.

Williams

, Nichols

Jr , Dent

, Allen

. Disturbances of the oxidative-phosphorylation mechanism as a possible etiological factor in sudden unexplained hyperpyrexia occurring during anesthesia. Anesthesiology 1966;27(2):231–232.

92.

Wang

, Moffitt

, Rosevear

. Oxidative phosphorylation in acute hyperthermia. Anesthesiology 1969;30(4):439–442.

93.

Fuchs

Thermal inactivation of the calcium regulatory mechanism of human skeletal muscle actinomyosin: A possible contributing factor in the rigidity of malignant hyperthermia. Anesthesiology 1975;42(5):584–589.